推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 王國強首先代表國家中醫(yī)藥管理局對媒體長期以來關(guān)心支持監(jiān)督、幫助中醫(yī)藥工作的發(fā)展，表示衷心的感謝。隨后，他回答了兩個問題。
第一個問題是如何加強中醫(yī)藥青年人才的培養(yǎng)。王國強回答稱，中醫(yī)藥人才的培養(yǎng)問題是制約中醫(yī)藥發(fā)展的關(guān)鍵問題。這些年來，我們高度重視人才的培養(yǎng)。一是高層人才的培養(yǎng)，發(fā)揮這些領(lǐng)軍人才、國醫(yī)大師的帶頭作用。另外，舉辦了關(guān)于中醫(yī)藥傳承優(yōu)秀人才的培養(yǎng)，取得了明顯成效。更重要的，針對基層人才的缺乏，通過各省舉行基層醫(yī)生相關(guān)技術(shù)培訓(xùn)。
第二個問題是關(guān)于《中醫(yī)藥法》的實施，國家中醫(yī)藥管理局有什么舉措。王國強表示，把貫徹落實這部法作為當(dāng)前的一件頭等大事，準(zhǔn)備做幾件事情：一是抓好面向社會和民眾的普法的宣傳。對民眾關(guān)心的熱點問題、重點問題進(jìn)行釋法和解讀。二是抓好各級政府和工作人員學(xué)法用法的培訓(xùn)，真正要做到依法行政，嚴(yán)格執(zhí)法。三是要抓好配套文件、規(guī)定、規(guī)范性文件的制定。目前正在抓緊調(diào)查研究，爭取在7月1日實施前出臺。四是這部法和其他法還有一些不相適應(yīng)的地方，其他法律法規(guī)怎么樣能夠更好的修改完善好，和《中醫(yī)藥法》的立法精神和有關(guān)規(guī)定更好的能夠銜接起來，這也是我們的任務(wù)。
“總而言之，我們要努力的把這部法貫徹落實好?！蓖鯂鴱姳硎尽?/p>
